Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VE1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,016
Award facts
- Contract value 100% obligated
- $14,016.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 15, 2026, represents a $14,016.48 firm fixed-price purchase of Myrbetriq ER 50 mg tablets (90-count) from Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Defense Logistics Agency (DLA) funded this non-competitive delivery order under its broader pharmaceutical supply framework supporting military healthcare systems. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement. The award carries an ultimate completion date of January 16, 2026, reflecting the expedited nature of pharmaceutical delivery orders within the DLA's supply chain.
This contract executes under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), a comprehensive global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to military treatment facilities and veteran healthcare programs. The non-set-aside designation indicates this award was made through open competition, consistent with Amerisourcebergen's established capability to meet federal procurement requirements for essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F7VE1?
SPE2DR26F7VE1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F7VE1 worth?
The government has obligated $14,016 on SPE2DR26F7VE1.
Is contract SPE2DR26F7VE1 an order under another contract?
Yes. SPE2DR26F7VE1 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VE1 competed?
The extent of competition for SPE2DR26F7VE1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award